News | May 17, 2010

Irrigated Ablation Catheter Introduced in Europe

May 17, 2010 – The first clinical cases using an irrigated ablation catheter were recently completed in the European Union, following recent CE Mark approval. The Thermocool SF irrigated ablation catheter is designed for use by electrophysiologists in treating cardiac arrhythmias.

The next generation irrigated ablation catheter builds on the previously cleared Thermocool irrigated catheter platform. The new catheter has a porous tip to provide uniform cooling and allows efficient cooling at half the flow rate.

The catheter offers localized cooling and uniform cooling of the entire catheter tip when ablating. This allows for efficient fluid delivery within the catheter itself and allows heat to dissipate across the entire catheter tip. As a result, cooling efficiency is increased and the flow rate is reduced.

“The Thermocool SF catheter is a new and exciting technology that represents a significant advancement in irrigated ablation for electrophysiologists,” said professor Gerd Hindricks of the Heart Center at the University of Leipzig Hospital. “My first clinical experience indicates that due to the strategic placement of the holes around the entire surface area of the tip, cooling efficiency and lesion induction may be improved to complete atrial fibrillation ablation procedures in a safe, effective, and timely manner.”

For more information: www.biosensewebster.com

Related Content

Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
Overlay Init